Latest Cancer Research Stories
Moving the Needle in Brain Tumor Survivorship through Genomic Sequencing Seattle, WA (PRWEB) February 05, 2014 On January 22nd, 2014 the
Brigham Young University scientists recently stumbled onto one potential tumor suppressor with an especially ominous name: Programmed Cell Death Protein 5 (aka PDCD5). What they found opens a new avenue for cancer researchers; in fact, the Journal of Biological Chemistry recognizes the work as their research paper of the week.
WESTLAKE, Ohio, Feb.
Co-inventors of ATM technology joining company as General Manager of the ATM Program, Scientific Advisory Panel member, respectively SYDNEY, Feb.
This report from BCC Research focuses on circulating tumor cell testing and monitoring methods, and includes an overview on cancer, diagnostic strategies, and treatment technologies.
NEW YORK, Jan.
Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, congratulates VABC Ambassador David Menasche on the launch of his book, The Priority List, which is
Studies address technical sensitivity, specificity, pharmacodynamics, heterogeneity and patient selection relevant to prostate cancer patient management SAN DIEGO and SAN FRANCISCO, Jan.
In response to a January 20, 2014 article published by Futurity.org, Voices Against Brain Cancer discusses a new backdoor approach to treating glioblastoma and what it could mean for the brain
- In dressmaking, straps running from the belt in front over the shoulders to the belt in the back, with more or less elaboration of trimming and outline. They usually broaden at the shoulder and narrow toward the waist.